{"drugs":["Ilevro","Nepafenac","Nevanac"],"mono":{"0":{"id":"928442-s-0","title":"Generic Names","mono":"Nepafenac"},"1":{"id":"928442-s-1","title":"Dosing and Indications","sub":{"0":{"id":"928442-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Extraction of cataract - Inflammatory disorder of the eye - Pain:<\/b> (0.3% suspension) 1 drop in affected eye once daily starting 1 day prior to surgery, the day of surgery, and continuing through the first 2 weeks postoperatively; apply 1 additional drop 30 to 120 minutes prior to surgery<\/li><li><b>Extraction of cataract - Inflammatory disorder of the eye - Pain:<\/b> (0.1% suspension) 1 drop in affected eye 3 times a day starting 1 day prior to surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period<\/li><\/ul>"},"1":{"id":"928442-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Extraction of cataract - Inflammatory disorder of the eye - Pain:<\/b> (0.3% suspension) 10 years or older, 1 drop in affected eye once daily starting 1 day prior to surgery, the day of surgery, and continuing through the first 2 weeks postoperatively; apply 1 additional drop 30 to 120 minutes prior to surgery<\/li><li><b>Extraction of cataract - Inflammatory disorder of the eye - Pain:<\/b> (0.1% suspension) 10 years or older, 1 drop in affected eye 3 times a day starting 1 day prior to surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period<\/li><\/ul>"},"3":{"id":"928442-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Extraction of cataract - Inflammatory disorder of the eye - Pain<br\/>"}}},"3":{"id":"928442-s-3","title":"Contraindications\/Warnings","sub":[{"id":"928442-s-3-9","title":"Contraindications","mono":"Prior hypersensitivity to nepafenac, any product component, or other NSAIDs <br\/>"},{"id":"928442-s-3-10","title":"Precautions","mono":"<ul><li>Endocrine Metabolic:<\/li><li>-- Diabetes mellitus; increased risk for sight-threatening corneal adverse events<\/li><li>Hematologic:<\/li><li>-- Use may increase bleeding time, especially in patients with bleeding tendencies or receiving concomitant medications that can prolong bleeding<\/li><li>Immunologic:<\/li><li>-- Rheumatoid arthritis; increased risk for sight-threatening corneal adverse events<\/li><li>Ophthalmic:<\/li><li>-- Increased bleeding in ocular tissues, including hyphema, may occur with NSAID instillation in conjunction with ocular surgery<\/li><li>-- Keratitis may develop with use of topical NSAIDs<\/li><li>-- Sight-threatening epithelial breakdown and corneal thinning, erosion, ulceration, or perforation may occur, especially with prolonged use (ie, more than 1 day before surgery or more than 14 days post-op); immediately discontinue if corneal epithelial breakdown develops<\/li><li>-- Increased risk of sight-threatening corneal adverse events among patients with a history of complicated or repeated ocular surgeries, corneal denervation, corneal epithelial defects, dry eye syndrome, or other ocular surface conditions<\/li><li>Other:<\/li><li>-- Delayed healing may occur<\/li><li>-- Do not instill in patients wearing contact lenses<\/li><\/ul>"},{"id":"928442-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"928442-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"928442-s-4","title":"Drug Interactions","sub":[{"id":"928442-s-4-13","title":"Contraindicated","mono":"<ul>Ketorolac (theoretical)<\/ul>"},{"id":"928442-s-4-14","title":"Major","mono":"<ul><li>Abciximab (theoretical)<\/li><li>Anagrelide (theoretical)<\/li><li>Apixaban (theoretical)<\/li><li>Ardeparin (probable)<\/li><li>Argatroban (theoretical)<\/li><li>Beta Glucan (theoretical)<\/li><li>Bivalirudin (theoretical)<\/li><li>Certoparin (probable)<\/li><li>Cilostazol (theoretical)<\/li><li>Citalopram (probable)<\/li><li>Clopidogrel (probable)<\/li><li>Clovoxamine (probable)<\/li><li>Cyclosporine (established)<\/li><li>Dabigatran Etexilate (theoretical)<\/li><li>Dalteparin (probable)<\/li><li>Danaparoid (probable)<\/li><li>Desirudin (theoretical)<\/li><li>Dipyridamole (theoretical)<\/li><li>Duloxetine (probable)<\/li><li>Edoxaban (established)<\/li><li>Enoxaparin (probable)<\/li><li>Eptifibatide (theoretical)<\/li><li>Erlotinib (theoretical)<\/li><li>Escitalopram (probable)<\/li><li>Femoxetine (probable)<\/li><li>Feverfew (theoretical)<\/li><li>Flesinoxan (probable)<\/li><li>Fluoxetine (probable)<\/li><li>Fondaparinux (theoretical)<\/li><li>Ginkgo (probable)<\/li><li>Gossypol (theoretical)<\/li><li>Heparin (theoretical)<\/li><li>Lepirudin (theoretical)<\/li><li>Levomilnacipran (theoretical)<\/li><li>Meadowsweet (theoretical)<\/li><li>Methotrexate (theoretical)<\/li><li>Milnacipran (probable)<\/li><li>Nadroparin (probable)<\/li><li>Nefazodone (probable)<\/li><li>Parnaparin (probable)<\/li><li>Paroxetine (probable)<\/li><li>Pemetrexed (theoretical)<\/li><li>Pentosan Polysulfate Sodium (theoretical)<\/li><li>Pentoxifylline (theoretical)<\/li><li>Pralatrexate (theoretical)<\/li><li>Prasugrel (theoretical)<\/li><li>Protein C (theoretical)<\/li><li>Reviparin (probable)<\/li><li>Rivaroxaban (theoretical)<\/li><li>Sibutramine (theoretical)<\/li><li>Tacrolimus (probable)<\/li><li>Ticlopidine (theoretical)<\/li><li>Tinzaparin (probable)<\/li><li>Tirofiban (theoretical)<\/li><li>Venlafaxine (probable)<\/li><li>Vilazodone (theoretical)<\/li><li>Vortioxetine (theoretical)<\/li><li>Zimeldine (probable)<\/li><\/ul>"},{"id":"928442-s-4-15","title":"Moderate","mono":"<ul><li>Acebutolol (probable)<\/li><li>Alacepril (established)<\/li><li>Alprenolol (probable)<\/li><li>Amiloride (probable)<\/li><li>Amlodipine (probable)<\/li><li>Arotinolol (probable)<\/li><li>Atenolol (probable)<\/li><li>Azilsartan (probable)<\/li><li>Azilsartan Medoxomil (probable)<\/li><li>Azosemide (probable)<\/li><li>Befunolol (probable)<\/li><li>Bemetizide (probable)<\/li><li>Benazepril (established)<\/li><li>Bendroflumethiazide (probable)<\/li><li>Benzthiazide (probable)<\/li><li>Bepridil (probable)<\/li><li>Betaxolol (probable)<\/li><li>Bevantolol (probable)<\/li><li>Bisoprolol (probable)<\/li><li>Bopindolol (probable)<\/li><li>Bucindolol (probable)<\/li><li>Bumetanide (probable)<\/li><li>Bupranolol (probable)<\/li><li>Buthiazide (probable)<\/li><li>Candesartan Cilexetil (probable)<\/li><li>Canrenoate (probable)<\/li><li>Captopril (established)<\/li><li>Carteolol (probable)<\/li><li>Carvedilol (probable)<\/li><li>Celiprolol (probable)<\/li><li>Chlorothiazide (probable)<\/li><li>Chlorpropamide (probable)<\/li><li>Chlorthalidone (probable)<\/li><li>Cilazapril (established)<\/li><li>Clopamide (probable)<\/li><li>Cyclopenthiazide (probable)<\/li><li>Delapril (established)<\/li><li>Desvenlafaxine (probable)<\/li><li>Dilevalol (probable)<\/li><li>Diltiazem (probable)<\/li><li>Enalapril (established)<\/li><li>Enalaprilat (established)<\/li><li>Eprosartan (probable)<\/li><li>Esmolol (probable)<\/li><li>Ethacrynic Acid (probable)<\/li><li>Felodipine (probable)<\/li><li>Flunarizine (probable)<\/li><li>Fosinopril (established)<\/li><li>Furosemide (probable)<\/li><li>Gallopamil (probable)<\/li><li>Glimepiride (probable)<\/li><li>Glipizide (probable)<\/li><li>Glyburide (probable)<\/li><li>Hydrochlorothiazide (probable)<\/li><li>Hydroflumethiazide (probable)<\/li><li>Imidapril (established)<\/li><li>Indapamide (probable)<\/li><li>Irbesartan (probable)<\/li><li>Isradipine (probable)<\/li><li>Labetalol (probable)<\/li><li>Lacidipine (probable)<\/li><li>Landiolol (probable)<\/li><li>Levobunolol (probable)<\/li><li>Lidoflazine (probable)<\/li><li>Lisinopril (established)<\/li><li>Losartan (probable)<\/li><li>Manidipine (probable)<\/li><li>Mepindolol (probable)<\/li><li>Methyclothiazide (probable)<\/li><li>Metipranolol (probable)<\/li><li>Metolazone (probable)<\/li><li>Metoprolol (probable)<\/li><li>Moexipril (established)<\/li><li>Nadolol (probable)<\/li><li>Nateglinide (probable)<\/li><li>Nebivolol (probable)<\/li><li>Nicardipine (probable)<\/li><li>Nifedipine (probable)<\/li><li>Nilvadipine (probable)<\/li><li>Nimodipine (probable)<\/li><li>Nipradilol (probable)<\/li><li>Nisoldipine (probable)<\/li><li>Nitrendipine (probable)<\/li><li>Olmesartan Medoxomil (probable)<\/li><li>Oxprenolol (probable)<\/li><li>Penbutolol (probable)<\/li><li>Pentopril (established)<\/li><li>Perindopril (established)<\/li><li>Pindolol (probable)<\/li><li>Piretanide (probable)<\/li><li>Polythiazide (probable)<\/li><li>Pranidipine (probable)<\/li><li>Propranolol (probable)<\/li><li>Quinapril (established)<\/li><li>Ramipril (established)<\/li><li>Repaglinide (probable)<\/li><li>Sotalol (probable)<\/li><li>Spirapril (established)<\/li><li>Spironolactone (probable)<\/li><li>Talinolol (probable)<\/li><li>Tasosartan (probable)<\/li><li>Telmisartan (probable)<\/li><li>Temocapril (established)<\/li><li>Tertatolol (probable)<\/li><li>Timolol (probable)<\/li><li>Tolazamide (probable)<\/li><li>Tolbutamide (probable)<\/li><li>Torsemide (probable)<\/li><li>Trandolapril (established)<\/li><li>Triamterene (probable)<\/li><li>Trichlormethiazide (probable)<\/li><li>Valsartan (probable)<\/li><li>Verapamil (probable)<\/li><li>Xipamide (probable)<\/li><li>Zofenopril (established)<\/li><\/ul>"}]},"5":{"id":"928442-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Ophthalmic:<\/b>Discharge from eye (5% to 10%), Disorder of lens capsule (5% to 10%), Foreign body sensation (5% to 10%), Raised intraocular pressure (5% to 10%), Reduced visual acuity (5% to 10%)<br\/><b>Serious<\/b><ul><li><b>Immunologic:<\/b>Impaired wound healing<\/li><li><b>Ophthalmic:<\/b>Corneal erosion, Corneal thinning, Corneal ulcer, Hyphema, Intraocular hemorrhage, Keratitis, Perforation of cornea, Vitreous detachment (1% to 5%)<\/li><\/ul>"},"6":{"id":"928442-s-6","title":"Drug Name Info","sub":{"0":{"id":"928442-s-6-17","title":"US Trade Names","mono":"<ul><li>Nevanac<\/li><li>Ilevro<\/li><\/ul>"},"2":{"id":"928442-s-6-19","title":"Class","mono":"<ul><li>Anti-Inflammatory<\/li><li>NSAID<\/li><\/ul>"},"3":{"id":"928442-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"928442-s-6-21","title":"Generic Availability","mono":"No<br\/>"}}},"8":{"id":"928442-s-8","title":"Pharmacokinetics","sub":[{"id":"928442-s-8-23","title":"Absorption","mono":"<ul><li>Tmax, 0.1% ophthalmic suspension: 3 hours (amfenac); 2 hours (nepafenac)<\/li><li>Tmax, 0.3% ophthalmic suspension: 0.75 hours (amfenac): 0.5 hours (nepafenac)<\/li><\/ul>"}]},"9":{"id":"928442-s-9","title":"Administration","mono":"<b>Ophthalmic<\/b><br\/><ul><li>Shake well before instillation<\/li><li>Do not administer while wearing contact lenses<\/li><li>Administer concomitant ophthalmic drugs at least 5 minutes apart<\/li><\/ul>"},"10":{"id":"928442-s-10","title":"Monitoring","mono":"Reduced pain and inflammation associated with cataract surgery is indicative of efficacy.<br\/>"},"11":{"id":"928442-s-11","title":"How Supplied","mono":"<ul><li><b>Ilevro<\/b><br\/>Ophthalmic Suspension: 0.3 %<br\/><\/li><li><b>Nevanac<\/b><br\/>Ophthalmic Suspension: 0.1 %<br\/><\/li><\/ul>"},"13":{"id":"928442-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause reduced visual acuity, conjunctival edema, or dryness, foreign body sensation, itching, photophobia, or hyperemia of the eye. Drug may also cause vitreous detachment or delayed healing.<\/li><li>Instruct patients using more than one ophthalmic medication to administer at least 5 minutes apart.<\/li><li>Instruct patient on proper instillation technique.<\/li><li>Patient should not administer drug while wearing contact lenses.<\/li><li>Advise patient to not use drug more than 14 days post-surgery, unless approved by healthcare professional, as this increases risk for adverse corneal effects.<\/li><li>Patient should not use aspirin or other NSAIDs while taking this drug, as these may prolong bleeding time.<\/li><li>Tell patient to avoid using topical forms of steroids or other NSAIDs, as these may cause delayed healing.<\/li><\/ul>"}}}